Related Experiment Video
Updated: May 13, 2026

Measuring Mitochondrial Function of Naïve and Effector CD8 T Cells
Published on: March 28, 2025
Regulation of mevalonate metabolism in cancer and immune cells
Martin Thurnher1, Georg Gruenbacher, Oliver Nussbaumer
1Department of Urology, Innsbruck Medical University, Austria. martin.thurnher@i-med.ac.at
Abstract:
The mevalonate pathway is a highly conserved metabolic cascade and provides isoprenoid building blocks for the biosynthesis of vital cellular products such as cholesterol or prenyl pyrophosphates that serve as substrates for the posttranslational prenylation of numerous proteins. The pathway, which is frequently hyperactive in cancer cells, is considered an important target in cancer therapy, since prenylated members of the Ras superfamily are crucially involved in the control of proliferation, survival, invasion and metastasis of tumour cells. Upstream accumulation and downstream depletion of mevalonate pathway intermediates as induced for instance by aminobisphosphonates translate into different effects in cancer and immune cells. Thus, mevalonate pathway regulation can affect tumour biology either directly or exhibit indirect antitumour effects through stimulating cancer immune surveillance. The present review summarizes major effects of pharmacologic mevalonate pathway regulation in cancer and immune cells that may collaboratively contribute to the efficacy of cancer therapy.
Insights
Targeting the mevalonate pathway offers a dual approach to cancer therapy. Modulating this pathway impacts tumor cell growth and enhances immune surveillance for improved cancer treatment.
Area of Science:
- Biochemistry
- Metabolic pathways
- Cancer biology
Background:
- The mevalonate pathway is essential for producing isoprenoids like cholesterol and prenyl pyrophosphates.
- These isoprenoids are crucial for protein prenylation, particularly for Ras superfamily proteins involved in cancer.
- The pathway is often overactive in cancer cells, making it a significant therapeutic target.
Purpose of the Study:
- To review the effects of pharmacologic regulation of the mevalonate pathway in cancer.
- To explore how this regulation impacts both cancer cells and immune cells.
- To understand the combined contribution to cancer therapy efficacy.
Main Methods:
- Literature review of studies on mevalonate pathway pharmacologic regulation.
- Analysis of effects on cancer cell proliferation, survival, invasion, and metastasis.
- Evaluation of impacts on immune cells and cancer immune surveillance.
Main Results:
- Pharmacologic interventions can alter mevalonate pathway intermediates, leading to upstream accumulation and downstream depletion.
- These alterations have differential effects on cancer cells versus immune cells.
- Mevalonate pathway regulation can directly affect tumor biology and indirectly boost anti-tumor immunity.
Conclusions:
- Modulating the mevalonate pathway presents a promising strategy for cancer therapy.
- The pathway's regulation influences tumor progression and immune response.
- Combined effects on cancer and immune cells may enhance overall therapeutic outcomes.
Related Concept Videos
Regulation of Metabolism
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

